Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.6500 (7.26%) ($6.2000 - $6.7500) on Fri. Jan. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.15% (three month average) | RSI | 81 | Latest Price | $6.6500(7.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2% a day on average for past five trading days. | Weekly Trend | CAPR advances 17.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) CEMB(11%) SHY(10%) PCY(9%) BNDX(8%) VCSH(8%) | Factors Impacting CAPR price | CAPR will decline at least -4.075% in a week (0% probabilities). BLOK(-24%) REMX(-16%) DRIV(-16%) XLK(-15%) VYM(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.075% (StdDev 8.15%) | Hourly BBV | 0 () | Intraday Trend | 7.3% | | | |
|
5 Day Moving Average | $6.49(2.47%) | 10 Day Moving Average | $6.24(6.57%) | 20 Day Moving Average | $5.38(23.61%) | To recent high | -37.9% | To recent low | 32.7% | Market Cap | $131m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |